Cargando...
A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers
In a double-blind placebo controlled trial intranasal NPC 567, a bradykinin antagonist, failed to alleviate the symptoms of experimental rhinovirus colds. Indeed, there was evidence that the drug enhanced the symptoms although no irritant effect was detected on the uninfected nasal mucosa.
Guardado en:
| Publicado en: | Antiviral Res |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Published by Elsevier B.V.
1990
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7134172/ https://ncbi.nlm.nih.gov/pubmed/1965113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/0166-3542(90)90052-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|